biotechnologyZevra Therapeutics risks collapse as 90% revenue depends on single rare disease drugViaNews Editorial Team•Feb 25, 2026
biotechnologyLeonaBio Risks $140M Market Cap on Single Breast Cancer Trial After Neurodegenerative PivotViaNews Editorial Team•Feb 22, 2026
